373
Views
1
CrossRef citations to date
0
Altmetric
Poison Centre Research

Clinical effects and outcomes of perampanel overdoses reported to U.S. poison centers

ORCID Icon, ORCID Icon &
Pages 239-242 | Received 28 Apr 2021, Accepted 14 Jun 2021, Published online: 19 Jul 2021

References

  • Krauss GL. Perampanel: a selective AMPA antagonist for treating seizures: perampanel: a selective AMPA antagonist. Epilepsy Curr. 2013;13(6):269–272.
  • Hoppner AC, Fauser S, Kerling F. Clinical course of intoxication with the new anticonvulsant drug perampanel. Epileptic Disord. 2013;15(3):362–364.
  • Kim S, Kim TE, Kim D, et al. Prolonged stupor in perampanel overdose and pharmacokinetic considerations. J Epilepsy Res. 2018;8(2):87–89.
  • Parsons G, Bailey J, Bailey F, et al. Prolonged unconsciousness in perampanel overdose. BMJ Case Rep. 2019;12(11):e232517.
  • Wu CC, McShane M, Huttlin EA, et al. Severe aggression after perampanel overdose: case report. Psychosomatics. 2019;60(3):321–324.
  • Tabuchi H, Shiba S, Yasuda S, et al. Pharmacokinetics of perampanel in healthy Korean, white, and Japanese adult subjects. Clin Pharmacol Drug Dev. 2018;7(6):613–620.
  • Qozi M, Cantrell FL. Pediatric perampanel poisoning. Am J Emerg Med. 2020;38(7):1545.
  • Gaudio E, Gienapp AJ, Wheless J. Perampanel pharmacokinetics in children: correlation of dose with serum concentrations. J Child Neurol. 2019;34(8):427–431.
  • Gidal BE, Ferry J, Majid O, et al. Concentration–effect relationships with perampanel in patients with pharmacoresistant partial‐onset seizures. Epilepsia. 2013;54(8):1490–1497.
  • Hibi S, Ueno K, Nagato S, et al. Discovery of 2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl)benzonitrile (perampanel): a novel, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) receptor antagonist. J Med Chem. 2012;55(23):10584–10600.
  • Li K, Lasoff DR, Smollin CG, et al. Perampanel overdose causing a prolonged coma. Clin Toxicol. 2018;56(7):677–678.
  • Steinhoff BJ, Hübers E, Kurth C, et al. Plasma concentration and clinical effects of perampanel-The Kork experience. Seizure. 2019;67:18–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.